Salazar, J.; Arranz, M.J.; Martin-Broto, J.; Bautista, F.; Martínez-García, J.; Martínez-Trufero, J.; Vidal-Insua, Y.; Echebarria-Barona, A.; Díaz-Beveridge, R.; Valverde, C.;
et al. Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol. Pharmaceutics 2024, 16, 1585.
https://doi.org/10.3390/pharmaceutics16121585
AMA Style
Salazar J, Arranz MJ, Martin-Broto J, Bautista F, Martínez-García J, Martínez-Trufero J, Vidal-Insua Y, Echebarria-Barona A, Díaz-Beveridge R, Valverde C,
et al. Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol. Pharmaceutics. 2024; 16(12):1585.
https://doi.org/10.3390/pharmaceutics16121585
Chicago/Turabian Style
Salazar, Juliana, María J. Arranz, Javier Martin-Broto, Francisco Bautista, Jerónimo Martínez-García, Javier Martínez-Trufero, Yolanda Vidal-Insua, Aizpea Echebarria-Barona, Roberto Díaz-Beveridge, Claudia Valverde,
and et al. 2024. "Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol" Pharmaceutics 16, no. 12: 1585.
https://doi.org/10.3390/pharmaceutics16121585
APA Style
Salazar, J., Arranz, M. J., Martin-Broto, J., Bautista, F., Martínez-García, J., Martínez-Trufero, J., Vidal-Insua, Y., Echebarria-Barona, A., Díaz-Beveridge, R., Valverde, C., Luna, P., Vaz-Salgado, M. A., Blay, P., Álvarez, R., & Sebio, A.
(2024). Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol. Pharmaceutics, 16(12), 1585.
https://doi.org/10.3390/pharmaceutics16121585